. Author manuscript; available in PMC: 2012 Nov 4.

Published in final edited form as: J Vasc Surg. 2006 Nov 21;45(1):2–9. doi: 10.1016/j.jvs.2006.08.048

Table III.

Spearman correlations between serum amyloid A, high sensitive CRP, and fibrinogen with baseline variables

Baseline Variable	Spearman r with SAA (p-value)	Spearman r with hsCRP (p-value)	Spearman r with Fib (p-value)
age	−.02 (.84)	.07 (.54)	−.05 (.64)
sex	.01 (.89)	−.09 (.41)	−.09 (.39)
race	.03 (.78)	.01 (.89)	.14 (.19)
CAD	.16 (.14)	.12 (.26)	.02 (.89)
DM	.38 (.0002)	.3 (.004)	.27 (.009)
ESRD	.27 (.012)	.3 (.004)	.18 (.09)
smoker	−.04 (.74)	−.12 (.25)	−.03 (.81)
HTN	.04 (.69)	−.09 (.42)	−.12 (.27)
hyperlipidemia	.07 (.52)	−.08 (.47)	−.09 (.38)
Statin use	.13 (.24)	−.03 (.75)	−.14 (.20)
critical limb ischemia	.28 (.008)	.33 (.001)	.35 (.0007)

SAA, Serum amyloid A; hsCRP, high-sensitivity C-reactive protein; Fib, fibrinogen; CAD, coronary artery disease; DM, diabetes mellitus; ESRD, end-stage renal disease; CLI, critical limb ischemia; HTN, hypertension.